OOIR: Observatory of International Research

Papers

(The TQCC of Pediatric Rheumatology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches	81
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey	69
Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology	37
Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)	36
COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country	33
Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children	32
Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus	30
Intravenous administration of anakinra in children with macrophage activation syndrome	27
Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype	26
Distinguishing active pediatric COVID-19 pneumonia from MIS-C	26
Growth and puberty in children with juvenile idiopathic arthritis	25
Neurological involvement in Kawasaki disease: a retrospective study	24
Telemedicine in pediatric rheumatology: this is the time for the community to embrace a new way of clinical practice	24
NLRP12-associated systemic autoinflammatory diseases in children	21
COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?	21
Post SARS-CoV-2 infection reactive arthritis: a brief report of two pediatric cases	21
Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)	19
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology	18
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab	17
Choroidal vascularity index as a biomarker of systemic inflammation in childhood Polyarteritis Nodosa and adenosine deaminase-2 deficiency	16
Proceedings of the 26th European Paediatric Rheumatology Congress: part 2	16
A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA)	16
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature	15
Telemedicine use by pediatric rheumatologists during the COVID-19 pandemic	15
Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study	15

Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?	15
Systemic inflammation and chronic kidney disease in a patient due to the RNASEH2B defect	14
Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases	14
Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER	14
Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature	14
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication	14
Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission	14
Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort	13
Similarities and differences between MIS-C and KD: a systematic review and meta-analysis	13
Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East	13
Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib	13
Pediatric rheumatology in Africa: thriving amidst challenges	13
Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019	13
Juvenile primary Fibromyalgia Syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis	13
Engaging patients and parents to improve mental health intervention for youth with rheumatological disease	12
Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania	12
Artificial intelligence for interpretation of segments of whole body MRI in CNO: pilot study comparing radiologists versus machine learning algorithm	12
Psychiatric disorders in incident patients with juvenile idiopathic arthritis - a case-control cohort study	12
Evaluating the performance of ACR, SLICC and EULAR/ACR classification criteria in childhood onset systemic lupus erythematosus	12
Evaluation of pediatric rheumatology telehealth satisfaction during the COVID-19 pandemic	12
The paediatric global musculoskeletal task force - ‘towards better MSK health for all’	12
Usefulness of magnetic resonance enterography in detecting signs of sacroiliitis in young patients with inflammatory bowel disease	11
Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention	11
Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic Lupus Erythematosus	11
Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline	11
Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review	11
Genetic and immunologic findings in children with recurrent aphthous stomatitis with systemic inflammation	11
Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials	11
Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases	11
Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis	10
Electronic forms for patient reported outcome measures (PROMs) are an effective, time-efficient, and cost-minimizing alternative to paper forms	10
Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective coho	10
Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study	10
Clinical characteristics and outcomes of chronic nonbacterial osteomyelitis in children: a multicenter case series	10
Disordered eating among adolescents with chronic pain: the experience of a pediatric rheumatology subspecialty pain clinic	10
Vitamin C deficiency mimicking inflammatory bone disease of the hand	10
Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares	10
Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review	10
Chronic nonbacterial osteomyelitis in children: a multicentre Belgian cohort of 30 children	10
Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs)	10
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients	10
A descriptive study on multisystem inflammatory syndrome in children in a single center in West Michigan	9
Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA	9
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial	9
Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature	9
Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists	9
Glitches in the utilization of telehealth in pediatric rheumatology patients during the COVID-19 pandemic	9
Adenosine deaminase 2 activity negatively correlates with age during childhood	9
Assessing the reporting quality of physical activity programs in randomized controlled trials for the management of juvenile idiopathic arthritis using three standardized assessment tools	9
The relationships of kinesiophobia and physical function and physical activity level in juvenile idiopathic arthritis	9

High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO)	9
Characteristics and genetic analysis of patients suspected with early-onset systemic lupus erythematosus	8
Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report	8
Epidemiology of pediatric uveitis and associated systemic diseases	8
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms	8
Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi–Goutie’res syndrome	8
Juvenile primary fibromyalgia syndrome: A Review- Treatment and Prognosis	8
In a large Juvenile Idiopathic Arthritis (JIA) cohort, concomitant celiac disease is associated with family history of autoimmunity and a more severe JIA course: a retrospective study	8
Juvenile Spondyloarthritis: focus on uveitis	8
A preliminary study of the child abuse and central sensitization in adolescent patients with chronic non-organic chest pain and an overlooked condition: juvenile fibromyalgia syndrome	8
Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach	8
Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis	8
Assessment of traditional and non-traditional risk factors for premature atherosclerosis in children with juvenile dermatomyositis and pediatric controls	8
Prosthetic temporomandibular joint reconstruction in a cohort of adolescent females with juvenile idiopathic arthritis	8
Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children	8
How children with juvenile idiopathic arthritis view participation and communication in healthcare encounters: a qualitative study	8
Lost bones: differential diagnosis of acro-osteolysis seen by the pediatric rheumatologist	8
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study	8
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents	7
Reproductive health needs of adolescent and young adult women with pediatric rheumatic diseases	7
Exploring the intersection of adverse childhood experiences, pediatric chronic pain, and rheumatic disease	7
Assessment of transition readiness in adolescents in Thailand with rheumatic diseases: a cross-sectional study	7
Factors impacting referral of JIA patients to a tertiary level pediatric rheumatology center in North India: a retrospective cohort study	7
TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases	7
Neonatal Kawasaki disease with multiple arterial aneurysms: a case report	7
Dutch patients, caregivers and healthcare professionals generate first nationwide research agenda for juvenile idiopathic arthritis	7
Leukocytoclastic vasculitis in patients with IL12B or IL12RB1 deficiency: case report and review of the literature	7
Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study	7
A systematic review exploring the bidirectional relationship between puberty and autoimmune rheumatic diseases	7
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study	7
Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort	7
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis	7
Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review	7
Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study	7
Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)	7
Magnetic resonance imaging findings in children with Parry-Romberg syndrome and en coup de sabre	7
Home-based exercise program for adolescents with juvenile dermatomyositis quarantined during COVID-19 pandemic: a mixed methods study	7
Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis	7
Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial	7
I don’t want to think about it: a qualitative study of children (6–18 years) with rheumatic diseases and parents’ experiences with regular needle injections at home	7
A novel mutation in early‐onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes	7
Clinical characteristics and genetic analysis of A20 haploinsufficiency	7
C-type natriuretic peptide stimulates osteoblastic proliferation and collagen-X expression but suppresses fibroblast growth factor-23 expression in vitro	6
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE	6
Anasarca as the presenting symptom of juvenile dermatomyositis: a case series	6
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series	6
Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China	6
Use of PROMIS® to screen for depression in children with arthritis	6
The spectrum of pediatric amplified musculoskeletal pain syndrome	6
Lung clearance index and diffusion capacity for CO to detect early functional pulmonary impairment in children with rheumatic diseases	6
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study	6
Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study	6
Salivary gland ultrasound in the diagnostic workup of juvenile Sjögren’s syndrome and mixed connective tissue disease	6
Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series	6
Developmentally appropriate transitional care during the Covid-19 pandemic for young people with juvenile-onset rheumatic and musculoskeletal diseases: the rationale for a position statement	6
Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience	6
The efficacy and safety of intra-articular injection of triamcinolone acetonide versus triamcinolone hexacetonide for treatment of juvenile idiopathic arthritis	6
Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies	6
Efficacy and safety of intraarticular corticosteroid injections in adolescents with juvenile idiopathic arthritis in the temporomandibular joint: a Norwegian 2-year prospective multicenter pilot study	6
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans	6
Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic	6
Outcomes of transitional care programs on adolescent chronic inflammatory systemic diseases: systematic review and meta-analyses	6
Age, gender, height and weight in relation to joint cartilage thickness among school-aged children from ultrasonographic measurement	6
IgA vasculitis nephritis clinical course and kidney biopsy – national study in children	6
Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases	6
Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids	6
Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review	6
Streptococcal infection in childhood Henoch-Schönlein purpura: a 5-year retrospective study from a single tertiary medical center in China, 2015–2019	6
Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus	6
Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report	6
Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis	6